Healthy Male Participants Clinical Trial
Official title:
A Phase I, Open-label Study to Evaluate the Absorption, Distribution, Metabolism, and Excretion, and to Assess the Absolute Bioavailability of AG-881 in Healthy Male Subjects Following Administration of a Single Oral Dose of [14C] AG-881 and Concomitant Intravenous Microdose of [13C315N3] AG-881
The purpose of this Phase I, open-label study is to evaluate the absorption, distribution, metabolism, excretion, absolute bioavailability, and to characterize the metabolites of AG-881 in healthy male participants following administration of a single oral dose of [14C] AG-881 and a concomitant intravenous microdose of [13C315N3] AG-881.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT06088264 -
A Study to Evaluate the Drug Levels, Metabolism, and Removal of BMS-986322 in Healthy Adult Male Participants
|
Phase 1 | |
| Completed |
NCT01707342 -
A Study to Assess the Absolute Bioavailability and Pharmacokinetics of Simeprevir (TMC435) Administered as Single Oral Doses of TMC435 and an Intravenous Microdose of [3H]-TMC435 in Healthy Male Patients
|
Phase 1 | |
| Active, not recruiting |
NCT06189508 -
A Study to Evaluate Single Subcutaneous Doses of NXT007 Among Injection Sites Abdomen, Upper Arm, and Thigh in Healthy Male Participants
|
Phase 1 | |
| Completed |
NCT03922633 -
A Single Intravenous Dose of E3112 in Japanese Healthy Adult Male Participants
|
Phase 1 | |
| Completed |
NCT03444818 -
A Study to Determine the Absorption, Metabolism, and Excretion of [14C]-E6007 After a Single Oral Administration in Healthy Male Participants
|
Phase 1 |